CIBC Asset Management Inc Has $709,000 Position in Stericycle, Inc. (SRCL)
CIBC Asset Management Inc increased its stake in shares of Stericycle, Inc. (NASDAQ:SRCL) by 0.2% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 9,287 shares of the business services provider’s stock after buying an additional 23 shares during the period. CIBC Asset Management Inc’s holdings in Stericycle were worth $709,000 as of its most recent filing with the SEC.
Several other large investors also recently added to or reduced their stakes in the stock. Kernodle & Katon Asset Management Group LLC bought a new stake in Stericycle during the first quarter valued at $100,000. Heritage Trust Co bought a new stake in Stericycle during the first quarter valued at $124,000. Pacer Advisors Inc. raised its stake in Stericycle by 3.3% in the first quarter. Pacer Advisors Inc. now owns 1,735 shares of the business services provider’s stock valued at $144,000 after buying an additional 55 shares in the last quarter. Invictus RG bought a new stake in Stericycle during the first quarter valued at $145,000. Finally, Morgan Dempsey Capital Management LLC raised its stake in Stericycle by 2.6% in the first quarter. Morgan Dempsey Capital Management LLC now owns 1,902 shares of the business services provider’s stock valued at $158,000 after buying an additional 48 shares in the last quarter. Institutional investors own 94.56% of the company’s stock.
Stericycle, Inc. (NASDAQ SRCL) opened at 71.95 on Tuesday. The firm’s market cap is $6.14 billion. Stericycle, Inc. has a 12-month low of $70.24 and a 12-month high of $88.00. The firm’s 50-day moving average price is $76.31 and its 200 day moving average price is $80.36.
Stericycle (NASDAQ:SRCL) last announced its quarterly earnings data on Thursday, August 3rd. The business services provider reported $1.15 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.13 by $0.02. The business had revenue of $917.70 million for the quarter, compared to analysts’ expectations of $902.81 million. Stericycle had a negative net margin of 0.07% and a positive return on equity of 14.35%. The firm’s quarterly revenue was up 2.9% compared to the same quarter last year. During the same period last year, the firm posted $1.18 earnings per share. Analysts forecast that Stericycle, Inc. will post $4.60 earnings per share for the current fiscal year.
ILLEGAL ACTIVITY NOTICE: “CIBC Asset Management Inc Has $709,000 Position in Stericycle, Inc. (SRCL)” was first posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this piece of content on another publication, it was illegally stolen and reposted in violation of US and international copyright and trademark legislation. The original version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/08/15/cibc-asset-management-inc-has-709000-position-in-stericycle-inc-srcl.html.
SRCL has been the topic of several analyst reports. Jefferies Group LLC set a $108.00 price objective on Stericycle and gave the company a “buy” rating in a research note on Thursday, August 3rd. Zacks Investment Research upgraded Stericycle from a “hold” rating to a “buy” rating and set a $85.00 price objective on the stock in a research note on Wednesday, July 5th. Deutsche Bank AG lowered their price objective on Stericycle from $14.00 to $10.00 and set a “buy” rating on the stock in a research note on Monday, May 15th. BMO Capital Markets initiated coverage on Stericycle in a research note on Thursday, June 29th. They issued a “market perform” rating and a $81.00 price objective on the stock. Finally, Barclays PLC restated an “overweight” rating and set a $100.00 price target on shares of Stericycle in a research report on Wednesday, August 9th. Four research analysts have rated the stock with a sell rating, six have issued a hold rating and six have issued a buy rating to the company. The company has an average rating of “Hold” and an average price target of $81.15.
Stericycle, Inc is a business-to-business services provider. The Company focuses on regulated and compliance solutions for healthcare, retail, and commercial businesses. The Company’s segments include Domestic and Canada Regulated Waste and Compliance Services (RCS), Domestic Communication and Related Services (CRS), International RCS and All other.
Receive News & Stock Ratings for Stericycle Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc. and related stocks with our FREE daily email newsletter.